Trajectories of Treatment Disruption for Chronic Outpatient Medications for U.S. Veterans During Drug Shortages.

Saved in:
Bibliographic Details
Title: Trajectories of Treatment Disruption for Chronic Outpatient Medications for U.S. Veterans During Drug Shortages.
Authors: Suda KJ; Center for Healthcare Evaluation, Research, and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA.; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Zhao X; Center for Healthcare Evaluation, Research, and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA., Aspinall SL; Center for Healthcare Evaluation, Research, and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA.; VA Center for Medication Safety/Pharmacy Benefits Management Services, Hines, Illinois, USA.; School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Li Y; Center for Healthcare Evaluation, Research, and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA., Callaway Kim K; Department of Pediatrics, Division of General Academic Pediatrics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Cunningham FE; VA Center for Medication Safety/Pharmacy Benefits Management Services, Hines, Illinois, USA., Boyer TL; Center for Healthcare Evaluation, Research, and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA., Miner TW; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Kima C; Center for Healthcare Evaluation, Research, and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA.; VA Center for Medication Safety/Pharmacy Benefits Management Services, Hines, Illinois, USA., Gellad WF; Center for Healthcare Evaluation, Research, and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA.; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Glassman PA; VA Pharmacy Benefits Management Services, Washington, DC, USA.; Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles, California, USA.; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Good CB; Center for Healthcare Evaluation, Research, and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA.; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Center for Value-Based Pharmacy Initiatives, UPMC Health Plan Insurance Services Division, Pittsburgh, Pennsylvania, USA., Skelton F; Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey VA Medical Center, Houston, Texas, USA.; H. Ben Taub Department of Physical Medicine and Rehabilitation, Baylor College of Medicine, Houston, Texas, USA., Tadrous M; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada., Thorpe CT; Center for Healthcare Evaluation, Research, and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA.; Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Source: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2026 Jun; Vol. 35 (6), pp. e70393.
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print Cited Medium: Internet ISSN: 1099-1557 (Electronic) Linking ISSN: 10538569 NLM ISO Abbreviation: Pharmacoepidemiol Drug Saf Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1099-1557
DOI:10.1002/pds.70393